ProCE Banner Activity

Advances in HIV Cure

Multimedia

Watch and listen as expert faculty provide insights on key concepts and mechanisms, recent clinical studies, important ethical considerations, and current directions in HIV cure research.

Released: November 10, 2022

Share

Faculty

Katharine J. Bar

Katharine J. Bar, MD

Associate Professor of Medicine
Director, Penn CFAR Virus and Reservoirs Core
University of Pennsylvania
Philadelphia, Pennsylvania

David M. Margolis

David M. Margolis, MD

Professor of Medicine, Microbiology & Immunology, Epidemiology
University of North Carolina School of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Katharine J. Bar, MD

Associate Professor of Medicine
Director, Penn CFAR Virus and Reservoirs Core
University of Pennsylvania
Philadelphia, Pennsylvania

Katharine Bar, MD: consultant/advisor/speaker: AbbVie.

David M. Margolis, MD

Professor of Medicine, Microbiology & Immunology, Epidemiology
University of North Carolina School of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

David M. Margolis, MD: consultant/advisor/speaker: Merck, ViiV Healthcare; researcher: Qura Therapeutics; individual publicly traded stocks and stock options: Gilead Sciences.